Factors Influencing the Prognosis of Olfactory Dysfunction After Upper Sensation

Launched by SECOND AFFILIATED HOSPITAL, SCHOOL OF MEDICINE, ZHEJIANG UNIVERSITY · Jun 8, 2021

Keywords

ClinConnect Summary

This clinical trial is studying how different doses of corticosteroids (a type of medication) can help people who have lost their sense of smell after having an upper respiratory infection, like a cold. Researchers want to find out which doses are most effective and what factors might influence recovery. The trial will look back at the medical records of patients treated between January 2020 and December 2025.

To be part of this study, participants must have had a confirmed upper respiratory infection and a normal sense of smell before becoming sick. Unfortunately, those with other reasons for losing their sense of smell won't be eligible. If you qualify and decide to participate, you will receive either oral corticosteroids for 12 days or inhaled corticosteroids for one month. The trial is not yet recruiting participants, so it's a good time to learn more and consider your options.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • The history of upper respiratory tract infection was confirmed, and the previous sense of smell was normal.
• Exclusion Criteria:
• • Other causes of olfactory disorder suggested by the history